CTIC · Categories · Form 4
CTIC - SEC Form 4 insider transactions
CTI BioPharma Corp. (DE) (CTIC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for CTIC
- SEC Form 4 filed by Bvf Partners L P/Il4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Parks Diane L.4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Fischer Laurent4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Perry Matthew D4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Tuckson Reed Vaughn4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Metzger Michael A4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Kirske David4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Craig Adam R4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Parkinson David Ross4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Fong James K4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Parkinson David Ross4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Metzger Michael A4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Parks Diane L.4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Tuckson Reed Vaughn4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Fischer Laurent4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Perry Matthew D4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Bvf Partners L P/Il4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Craig Adam R4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Kirske David4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Fong James K4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Craig Adam R exercised 85,317 shares at a strike of $0.84 and sold $511,923 worth of shares (85,317 units at $6.00) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Fong James K exercised 100,000 shares at a strike of $0.95 and sold $600,000 worth of shares (100,000 units at $6.00) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Craig Adam R exercised 115,583 shares at a strike of $0.84, sold $694,672 worth of shares (115,583 units at $6.01) as part of a pre-agreed trading plan and was granted 1,579 shares, increasing direct ownership by 6% to 29,440 units4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Kirske David was granted 214 shares, exercised 54,042 shares at a strike of $0.95 and sold $324,564 worth of shares (54,042 units at $6.01) as part of a pre-agreed trading plan, increasing direct ownership by 1% to 17,127 units4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Craig Adam R exercised 242,300 shares at a strike of $0.84 and sold $1,454,760 worth of shares (242,300 units at $6.00) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Metzger Michael A exercised 91,500 shares at a strike of $0.95 and sold $511,019 worth of shares (91,500 units at $5.58) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Kirske David exercised 2,109 shares at a strike of $0.95 and sold $13,194 worth of shares (2,109 units at $6.26) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Kirske David exercised 141,041 shares at a strike of $0.95 and sold $852,825 worth of shares (141,041 units at $6.05) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Kirske David sold $136,004 worth of shares (22,592 units at $6.02) as part of a pre-agreed trading plan, was granted 9,516 shares and exercised 22,592 shares at a strike of $0.95, increasing direct ownership by 129% to 16,913 units4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Craig Adam R exercised 242,300 shares at a strike of $0.84 and sold $1,557,989 worth of shares (242,300 units at $6.43) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Craig Adam R bought $27,500 worth of shares (5,000 units at $5.50), increasing direct ownership by 22% to 27,861 units4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Bvf Partners L P/Il sold $52,020,000 worth of shares (8,500,000 units at $6.12) and converted options into 8,383,331 shares4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Metzger Michael A sold $130,995 worth of shares (20,121 units at $6.51) as part of a pre-agreed trading plan, closing all direct ownership in the company4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Metzger Michael A exercised 91,500 shares at a strike of $0.84 and sold $556,067 worth of shares (91,500 units at $6.08) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Craig Adam R exercised 72,223 shares at a strike of $0.84, sold $435,343 worth of shares (72,223 units at $6.03) as part of a pre-agreed trading plan and was granted 6,183 shares, increasing direct ownership by 37% to 22,861 units4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Kirske David exercised 60,000 shares at a strike of $2.92 and sold $372,505 worth of shares (60,000 units at $6.21) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Kirske David exercised 10,000 shares at a strike of $0.95 and sold $55,000 worth of shares (10,000 units at $5.50) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Craig Adam R (Amendment)4/A - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Craig Adam R exercised 72,223 shares at a strike of $0.84 and sold $433,520 worth of shares (72,223 units at $6.00) as part of a pre-agreed trading plan4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Bvf Partners L P/Il4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Tuckson Reed Vaughn4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Perry Matthew D4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Parks Diane L.4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Parkinson David Ross4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Metzger Michael A4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Fischer Laurent4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Kirske David was granted 3,599 shares, increasing direct ownership by 95% to 7,397 units4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Seeley Bruce J. was granted 6,405 shares, increasing direct ownership by 17% to 43,905 units4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Craig Adam R was granted 3,178 shares, increasing direct ownership by 24% to 16,678 units4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: Craig Adam R was granted 5,000 shares and bought $5,337 worth of shares (3,500 units at $1.52), increasing direct ownership by 170% to 13,500 units4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: P/Il L Partners Bvf bought $5,000,000 worth of Common Stock (2,000,000 units at $2.50)4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by P/Il L Partners Bvf4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Vaughn Reed Tuckson4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by A Michael Metzger4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by D Matthew Perry4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Ross David Parkinson4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4 filed by Laurent Fischer4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: J. Bruce Seeley was granted 5,000 units of Common Stock, increasing direct ownership by 15% to 37,500 units4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: David Kirske was granted 3,798 units of Common Stock4 - CTI BIOPHARMA CORP (0000891293) (Issuer)
- SEC Form 4: R Adam Craig was granted 5,000 units of Common Stock4 - CTI BIOPHARMA CORP (0000891293) (Issuer)